- AU$272.31m
- AU$1.20bn
- AU$1.37bn
Brief: Australian Clinical Labs Announces Extension Of Takeover Offer Period For Healius Ltd
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: Australia's ACCC Consults On ACL's Proposed Divestiture For Healius Bid
Regulator asks Australian Clinical to divest collection centres for Healius buyout (updated)
Regulator asks Australian Clinical Labs to divest collection centres
Brief: Australian Clinical Labs Provides Update on ACCC Review Timeline On Takeover Offer for Healius
Brief: Australian Clinical Labs Ltd Says Update On Offer For Healius
Morgan Stanley cuts PT, earnings view for Australia's Healius
Citi lowers PT on Australia's Healius as FY results miss analyst view
Brief: Healius Enters FY 2024 With Momentum It Achieved In 2H 2023
Brief: Australia's ACCC Says ACL'S Proposed Acquisition Of Healius Raises Concerns
Regulator flags concerns on Australian Clinical's buyout offer for Healius (updated)
Regulator flags concerns on Australian Clinical's buyout offer for Healius
Brief: Healius Notes Release Of Australian Clinical Labs Limited's Second Supplementary Bidder's Statement
Brief: Australian Clinical Labs Responds To Healius' Target's Statement
Brief: Australian Clinical Labs Says Reviewing Healius' Target's Statement
Deals of the day-Mergers and acquisitions
Australian Clinical Labs falls after Healius rejects buyout bid